ABC Arbitrage’s Cidara Therapeutics CDTX Stock Holding History

ABC Arbitrage’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,894	Closed	-$6.6M	–	388
2025 Q4	$6.6M	Buy	+29,894	New	+$4.83M	0.62%	37

ABC Arbitrage's CDTX Position: Q1 2026 in Review

ABC Arbitrage sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 29,894 shares — an estimated $6.6M sold.

ABC Arbitrage first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $6.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

ABC Arbitrage reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
ABC Arbitrage sold 29,894 Cidara Therapeutics shares in Q1 2026, an estimated $6.6M.
ABC Arbitrage first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
ABC Arbitrage's Cidara Therapeutics position peaked at $6.6M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on ABC Arbitrage's 13F filing for Q1 2026, filed 4 May 2026.